Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Minimal Change Disease: early-phase trial registry
7 of 7 indexed Minimal Change Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 7 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Minimal Change Disease: 7 US clinical trials tracked, 7 recruiting.
Minimal Change Disease is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of Michigan, running 3 of these trials.
Enrollment posture brief
Registry condition minimal-change-disease
OPEN 7 | RECR 100% | LATE 0 | EARLY 2 | RANK #2497 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Minimal Change Disease lists 7 open slots (100% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Minimal Change Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Minimal Change Disease is recruiting above its size-band peers.
7 of 7 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Minimal Change Disease research.
University of Michigan accounts for 3 of 7 trials (42.9%). 4 distinct sponsors appear on at least one study for this condition label.
-
Typical Minimal Change Disease enrolment sits around 96 participants.
Median target enrolment is 96 among the 7 trials that report a genuine target (sentinel values excluded). 4 of those (57.1%) plan for fewer than 100 participants.
-
Minimal Change Disease research is mostly interventional.
5 interventional and 2 observational studies make up this index (71.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
NEPTUNE Match Study
University of Michigan
NCT04571658
Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease
University of Michigan
NCT05650619
Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
University of Michigan
NCT05505500
Study of WAL0921 in Patients With Glomerular Kidney Diseases
Walden Biosciences
NCT06466135
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Travere Therapeutics
NCT05003986
taVNS for FRNS in Children
Northwell Health
NCT05588063
A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)
Northwell Health
NCT05583942
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Minimal Change Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Minimal Change Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Minimal Change Disease page
7 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Minimal Change Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Michigan sponsors the most Minimal Change Disease trials on record, review their full trial history before evaluating a specific study. See University of Michigan's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Minimal Change Disease condition card totals 7 registered trials; most-linked intervention Sham device; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.